CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 155693-155979 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"A cohort of 6 dogs with persistent cytopenia, and bone marrow cytology and/or core biopsy diagnosis of AML were treated with same day doxorubicin at 30 mg/m 2 or 1 mg/kg IV over 20 minutes, followed by cytarabine at 300 mg/m 2 with constant rate IV infusion over 4 hours, every 14 days.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1150","span":{"begin":0,"end":286},"obj":"Sentence"},{"id":"T72824","span":{"begin":0,"end":286},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1150","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T72824","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T355","span":{"begin":50,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A355","pred":"uberon_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"},{"subj":"T355","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T528","span":{"begin":103,"end":106},"obj":"Disease"},{"id":"T53285","span":{"begin":103,"end":106},"obj":"Disease"}],"attributes":[{"id":"A528","pred":"mondo_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A529","pred":"mondo_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A68653","pred":"mondo_id","subj":"T53285","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A73562","pred":"mondo_id","subj":"T53285","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"subj":"T528","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T53285","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T313","span":{"begin":103,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A313","pred":"hp_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"subj":"T313","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93bfec","default":true},{"id":"CORD-19-PD-UBERON","color":"#d9ec93"},{"id":"CORD-19-PD-MONDO","color":"#e593ec"},{"id":"CORD-19-PD-HP","color":"#93eccb"}]}]}}